Summary
Active pharmaceutical ingredients (API), usually referred to as chemical raw materials, are active ingredients in chemical pharmaceutical preparations. Driven by multiple factors such as population growth and aging, the cliff of international patented drugs, the transfer of global raw material production capacity, and the promotion of drug penetration through volume purchases, chemical raw materials have achieved continuous growth as the upstream of chemical preparations, but at the same time they are also facing challenges. The pressure of environmental protection is increasing day by day, technical barriers are rising and other development bottlenecks.
my country is the world’s largest producer and exporter of APIs. The chemical API industry is developing rapidly, with continuous improvements in industrial scale, production technology, and quality. At the same time, it is also in the process of adjusting the industrial structure, improving the industrial layout, and improving the level of green production. In the upgrading stage, accelerate the pace of high-quality industrial development.
As competition continues to escalate, raw materials usher in an opportunity for strategic development
The growth of the global population and the intensification of aging promote the continuous growth of the pharmaceutical market, the arrival of the superimposed patent cliff, and the accelerated development of generic drugs, which also drives the continuous growth of the demand for upstream APIs. Internationally, the epidemic has led to continuous tightening of the global supply chain. Asia, especially China, has accelerated the transfer of global industries with its good epidemic prevention and control capabilities and a complete industrial chain foundation; domestically, regulation and environmental protection jointly promote industrial transformation and upgrading and structural optimization. Raw materials ushered in an opportunity for development.
Steady market growth: Prospects for specialty APIs and patented APIs
Except for the decline in 2020 due to the impact of the epidemic, the global API market has shown a steady growth trend. It rose from US$130.8 billion in 2015 to US$175 billion in 2019, with an average annual compound growth rate of 7.5%. In 2020, it will decline due to the impact of the epidemic, but it will return to the right track in 2021. The increase in the variety and quantity of generic drugs will drive the growth of the production of raw materials, which is expected to reach 290 billion US dollars by 2026, with an average annual compound growth rate of more than 10%.
The main business income of my country’s API industry has rebounded. In recent years, with the appreciation of the renminbi, changes in the export tax rebate rate, rising prices of raw materials such as grain and chemical raw materials, rising labor costs, and stricter policies, the low-end production capacity of chemical raw materials has accelerated. The overall revenue in 2018 There was a more obvious decline, and then rebounded. It is expected to reach 426.5 billion yuan in 2021, with a growth rate of 8.1%, returning to the upward channel.
To view the full report please click
Note: Unless marked as original, all are contributions and sharing by netizens or institutions. If you have any publicity needs, please contact [email protected].
This article is transferred from: https://www.dx2025.com/archives/27859.html
This site is only for collection, and the copyright belongs to the original author.